August 14, 2025

Who Benefits From Vaccine Misinformation?

US vaccination rates have declined in recent years, coinciding with increased public debate over vaccine safety and policy.

KFF Health News

August 14, 2025

Are Immigration Raids Sending Patients Online?

Clinics and health plans are expanding telehealth services as increased immigration enforcement has coincided with some patients, including immigrant families, delaying or avoiding in-person medical visits.

KFF Health News

August 07, 2025

Flu Treatment Linked to Lower Neuropsychiatric Risk in Pediatric and Adolescent Patients

Subgroup analyses demonstrated a greater reduction in neurologic events than psychiatric events, though the reduction in psychiatric events was not statistically significant.

Conexiant

August 06, 2025

UV Light Linked With Lower Respiratory Infection Rates 

Researchers found that germicidal UV light modestly reduced total respiratory infections in long-term care facilities for older adults.

Conexiant

July 31, 2025

AAP Releases 2025-2026 Flu Guidance

Experts encourage early influenza vaccination in children to reduce severe illness and hospitalization, especially among medically vulnerable and underserved populations.

Conexiant

July 24, 2025

Maternal RSV Vaccine Shows 72% Effectiveness

Following national rollout, UK data provide early post-licensure evidence supporting maternal RSV vaccination as a real-world strategy to lower infant hospital admissions.

Conexiant

July 24, 2025

HHS Ends Thimerosal Use in Flu Vaccines

The U.S. Department of Health and Human Services has adopted a CDC advisory panel recommendation to remove thimerosal from all influenza vaccines, transitioning entirely to mercury-free, single-dose formulations.

Conexiant

July 21, 2025

Stanford Physician-Scientist Takes CDER Helm

Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs.

Conexiant

July 16, 2025

New Guidelines Target Preventive Gaps in Inflammatory Bowel Disease

New clinical recommendations detail updated vaccination and screening protocols to reduce infection and cancer risks in adults with inflammatory bowel disease, particularly those on immune-modifying therapies.

Conexiant